What is Enovis Corp's earnings per share (EPS)?

Enovis Corp (ENOV) reported diluted earnings per share of $-20.75 for fiscal year 2025. This represents a -39.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Enovis Corp Financials

ENOV

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Enovis Corp (ENOV) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 32/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Enovis Corp has an operating margin of -50.0%, meaning the company retains $-50 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from -36.8% the prior year.

Growth

Enovis Corp's revenue grew 6.7% year-over-year to $2.2B, a solid pace of expansion. This earns a growth score of 44/100.

Leverage

Enovis Corp carries a low D/E ratio of 0.85, meaning only $0.85 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 85/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Enovis Corp's current ratio of 2.02 indicates adequate short-term liquidity, earning a score of 37/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

While Enovis Corp generated $217.3M in operating cash flow, capex of $197.4M consumed most of it, leaving $19.9M in free cash flow. This results in a low score of 27/100, reflecting heavy capital investment rather than weak cash generation.

Returns

Enovis Corp generates a -79.5% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from -32.2% the prior year.

Piotroski F-Score Neutral

4/9

Enovis Corp passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Mixed

-0.18x

For every $1 of reported earnings, Enovis Corp generates $-0.18 in operating cash flow ($217.3M OCF vs -$1.2B net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk

-32.3x

Enovis Corp earns $-32.3 in operating income for every $1 of interest expense (-$1.1B vs $34.8M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.2B

YoY+6.7%

5Y CAGR+14.9%

10Y CAGR-7.0%

Enovis Corp generated $2.2B in revenue in fiscal year 2025. This represents an increase of 6.7% from the prior year.

EBITDA

$219.9M

YoY+44.6%

5Y CAGR+16.7%

10Y CAGR-9.3%

Enovis Corp's EBITDA was $219.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 44.6% from the prior year.

Net Income

-$1.2B

YoY-43.5%

Enovis Corp reported -$1.2B in net income in fiscal year 2025. This represents a decrease of 43.5% from the prior year.

EPS (Diluted)

$-20.75

YoY-39.0%

Enovis Corp earned $-20.75 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 39.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$19.9M

YoY+129.6%

5Y CAGR-36.1%

10Y CAGR-23.8%

Enovis Corp generated $19.9M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 129.6% from the prior year.

Cash & Debt

$36.4M

YoY-24.5%

5Y CAGR-17.8%

10Y CAGR-19.2%

Enovis Corp held $36.4M in cash against $1.3B in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

57M

YoY+2.4%

5Y CAGR-13.6%

10Y CAGR-7.4%

Enovis Corp had 57M shares outstanding in fiscal year 2025. This represents an increase of 2.4% from the prior year.

Margins & Returns

Gross Margin

59.8%

YoY+3.8pp

5Y CAGR+6.0pp

10Y CAGR+27.9pp

Enovis Corp's gross margin was 59.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 3.8 percentage points from the prior year.

Operating Margin

-50.0%

YoY-13.2pp

5Y CAGR-44.1pp

10Y CAGR-58.9pp

Enovis Corp's operating margin was -50.0% in fiscal year 2025, reflecting core business profitability. This is down 13.2 percentage points from the prior year.

Net Margin

-52.7%

YoY-13.5pp

5Y CAGR-56.5pp

10Y CAGR-61.2pp

Enovis Corp's net profit margin was -52.7% in fiscal year 2025, showing the share of revenue converted to profit. This is down 13.5 percentage points from the prior year.

Return on Equity

-79.5%

YoY-47.3pp

5Y CAGR-80.7pp

10Y CAGR-92.0pp

Enovis Corp's ROE was -79.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 47.3 percentage points from the prior year.

Capital Allocation

R&D Spending

$120.3M

YoY+31.8%

5Y CAGR+28.6%

Enovis Corp invested $120.3M in research and development in fiscal year 2025. This represents an increase of 31.8% from the prior year.

Share Buybacks

$3.5M

YoY-26.6%

Enovis Corp spent $3.5M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 26.6% from the prior year.

Capital Expenditures

$197.4M

YoY+9.2%

5Y CAGR+11.5%

10Y CAGR+8.9%

Enovis Corp invested $197.4M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 9.2% from the prior year.

ENOV Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$2.2B+6.7%	$2.1B+23.5%	$1.7B+9.2%	$1.6B+9.6%	$1.4B+27.3%	$1.1B
Cost of Revenue	$902.8M-2.6%	$926.9M+29.4%	$716.4M+3.3%	$693.7M+7.0%	$648.5M+25.4%	$517.1M
Gross Profit	$1.3B+13.9%	$1.2B+19.2%	$990.8M+14.0%	$869.4M+11.8%	$777.7M+28.8%	$603.6M
R&D Expenses	$120.3M+31.8%	$91.3M+21.2%	$75.3M+23.8%	$60.8M+23.9%	$49.1M+43.3%	$34.3M
SG&A Expenses	$1.1B+4.2%	$1.0B+23.7%	$830.3M+7.4%	$772.9M+16.1%	$665.8M+29.2%	$515.5M
Operating Income	-$1.1B-44.9%	-$775.7M-1080.5%	-$65.7M+7.7%	-$71.2M-13.3%	-$62.8M+5.1%	-$66.2M
Interest Expense	$34.8M-39.0%	$57.1M+189.1%	$19.7M-17.9%	$24.1M-17.4%	$29.1M-44.9%	$52.8M
Income Tax	$22.3M+396.3%	$4.5M+133.8%	-$13.3M-136.8%	$36.1M+285.0%	-$19.5M+56.2%	-$44.6M
Net Income	-$1.2B-43.5%	-$825.5M-2381.9%	-$33.3M-150.2%	-$13.3M-118.5%	$71.7M+68.1%	$42.6M
EPS (Diluted)	$-20.75-39.0%	$-14.93-2347.5%	$-0.61-144.0%	$-0.25-117.9%	$1.40+50.5%	$0.93

Metric	Q4'25	Q3'25	Q2'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Revenue	$548.9M-2.8%	$564.5M+1.0%	$558.8M-0.4%	$561.0M+11.0%	$505.2M-3.8%	$525.2M+1.7%	$516.3M+13.5%	$455.0M
Cost of Revenue	$220.0M-4.3%	$229.8M+1.4%	$226.6M-10.6%	$253.5M+15.9%	$218.8M-7.4%	$236.3M+8.2%	$218.4M+14.6%	$190.6M
Gross Profit	$328.9M-1.7%	$334.7M+0.7%	$332.2M+8.0%	$307.5M+7.4%	$286.5M-0.8%	$288.9M-3.0%	$297.9M+12.7%	$264.4M
R&D Expenses	$29.7M-3.1%	$30.7M+7.6%	$28.5M+19.1%	$24.0M+16.9%	$20.5M-12.7%	$23.5M+0.4%	$23.4M+27.6%	$18.3M
SG&A Expenses	$263.6M-1.3%	$267.1M-0.7%	$269.0M+4.4%	$257.7M+3.1%	$249.9M-5.4%	$264.1M+3.3%	$255.7M+21.2%	$211.0M
Operating Income	-$558.5M-3225.1%	-$16.8M+64.1%	-$46.8M+93.0%	-$664.7M-1994.6%	-$31.7M+28.2%	-$44.2M-26.3%	-$35.0M-508.4%	-$5.8M
Interest Expense	$8.8M-5.0%	$9.3M+1.2%	$9.2M+1.3%	$9.1M-18.0%	$11.1M-34.8%	$17.0M-15.1%	$20.0M+370.2%	$4.3M
Income Tax	$4.0M-62.9%	$10.8M+710.6%	-$1.8M-105.9%	$29.9M+428.7%	-$9.1M-2.1%	-$8.9M-20.3%	-$7.4M-261.3%	$4.6M
Net Income	-$571.1M-1454.6%	-$36.7M+34.4%	-$56.0M+92.0%	-$703.3M-2131.3%	-$31.5M-69.1%	-$18.6M+74.1%	-$72.0M-2529.1%	$3.0M
EPS (Diluted)	$-9.99-1460.9%	$-0.64+34.7%	$-0.98	N/A	$-0.58-70.6%	$-0.34+74.2%	$-1.32	N/A

ENOV Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$3.8B-18.7%	$4.7B+4.6%	$4.5B+5.5%	$4.3B-49.8%	$8.5B+15.8%	$7.4B
Current Assets	$1.2B+5.3%	$1.1B+27.9%	$896.5M+12.8%	$795.0M-65.5%	$2.3B+69.1%	$1.4B
Cash & Equivalents	$36.4M-24.5%	$48.2M+33.1%	$36.2M+49.0%	$24.3M-96.4%	$680.3M+600.8%	$97.1M
Inventory	$584.4M+6.8%	$547.1M+16.7%	$468.8M+9.9%	$426.6M+19.8%	$356.2M-36.9%	$564.8M
Accounts Receivable	$442.8M+8.8%	$407.0M+39.6%	$291.5M+9.0%	$267.4M+4.9%	$255.0M-50.7%	$517.0M
Goodwill	$718.3M-57.6%	$1.7B-17.9%	$2.1B+3.9%	$2.0B+2.6%	$1.9B+9.8%	$1.8B
Total Liabilities	$2.3B+8.7%	$2.2B+97.9%	$1.1B+32.2%	$823.4M-78.6%	$3.9B+2.4%	$3.8B
Current Liabilities	$598.5M+13.1%	$529.0M+43.1%	$369.6M-34.6%	$565.2M-44.8%	$1.0B+26.1%	$811.7M
Long-Term Debt	$1.3B-3.6%	$1.3B+180.9%	$466.2M+1065.4%	$40.0M-98.1%	$2.1B-5.7%	$2.2B
Total Equity	$1.5B-41.9%	$2.6B-25.0%	$3.4B-0.9%	$3.4B-25.3%	$4.6B+30.3%	$3.5B
Retained Earnings	-$1.5B-418.5%	-$283.0M-152.2%	$542.5M-5.8%	$575.7M-2.3%	$589.0M+13.9%	$517.4M

Metric	Q4'25	Q3'25	Q2'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Total Assets	$4.4B-11.7%	$5.0B+3.0%	$4.9B+3.3%	$4.7B-15.0%	$5.6B+2.0%	$5.4B-0.7%	$5.5B+21.5%	$4.5B
Current Assets	$1.3B0.0%	$1.3B+5.1%	$1.2B+6.3%	$1.1B-4.7%	$1.2B+2.6%	$1.2B+1.9%	$1.2B+28.4%	$896.5M
Cash & Equivalents	$33.6M-23.7%	$44.1M+14.6%	$38.5M-20.2%	$48.2M+36.0%	$35.4M+1.2%	$35.0M-47.2%	$66.3M+83.1%	$36.2M
Inventory	$613.8M-2.3%	$628.2M+7.2%	$585.9M+7.1%	$547.1M-10.3%	$609.7M-0.9%	$615.0M+5.0%	$586.0M+25.0%	$468.8M
Accounts Receivable	$431.8M-4.8%	$453.7M+4.2%	$435.6M+7.0%	$407.0M+1.7%	$400.2M+1.4%	$394.7M+3.6%	$381.1M+30.7%	$291.5M
Goodwill	$1.2B-31.6%	$1.8B+2.8%	$1.7B+2.4%	$1.7B-29.3%	$2.4B+1.7%	$2.4B-2.5%	$2.4B+17.2%	$2.1B
Total Liabilities	$2.4B-1.3%	$2.4B+8.2%	$2.3B+4.7%	$2.2B-2.8%	$2.2B+3.0%	$2.2B-0.7%	$2.2B+99.1%	$1.1B
Current Liabilities	$575.4M+1.3%	$568.2M+19.0%	$477.4M-9.7%	$529.0M-0.2%	$530.2M+2.4%	$518.0M-5.7%	$549.1M+48.6%	$369.6M
Long-Term Debt	$1.3B-2.5%	$1.4B+0.4%	$1.4B+4.4%	$1.3B-1.2%	$1.3B-0.3%	$1.3B+0.8%	$1.3B+182.8%	$466.2M
Total Equity	$2.0B-21.6%	$2.6B-1.5%	$2.6B+2.2%	$2.6B-23.1%	$3.3B+1.3%	$3.3B-0.7%	$3.3B-3.2%	$3.4B
Retained Earnings	-$946.9M-152.0%	-$375.7M-10.8%	-$339.0M-19.8%	-$283.0M-167.3%	$420.3M-7.0%	$451.8M-4.0%	$470.5M-13.3%	$542.5M

ENOV Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$217.3M+91.4%	$113.5M-15.9%	$135.0M+341.6%	-$55.9M-115.7%	$356.1M+17.9%	$301.9M
Capital Expenditures	$197.4M+9.2%	$180.7M+47.9%	$122.2M+15.9%	$105.5M+1.2%	$104.2M-9.2%	$114.8M
Free Cash Flow	$19.9M+129.6%	-$67.2M-626.5%	$12.8M+107.9%	-$161.3M-164.0%	$251.9M+34.6%	$187.2M
Investing Cash Flow	-$179.4M+81.2%	-$955.5M-294.1%	-$242.5M-37.5%	-$176.4M+45.0%	-$320.5M-83.0%	-$175.1M
Financing Cash Flow	-$52.4M-106.2%	$846.8M+562.6%	$127.8M+127.5%	-$465.1M-179.5%	$584.9M+544.3%	-$131.7M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$3.5M-26.6%	$4.8M	$0	$0	N/A	$0

Metric	Q4'25	Q3'25	Q2'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Operating Cash Flow	$82.6M+72.9%	$47.8M+3093.0%	-$1.6M-101.8%	$88.3M+64.9%	$53.6M+589.0%	$7.8M+121.5%	-$36.2M-152.8%	$68.4M
Capital Expenditures	$53.5M+20.6%	$44.4M+2.6%	$43.3M-18.7%	$53.2M+3.9%	$51.2M+29.9%	$39.4M+6.7%	$36.9M+32.2%	$27.9M
Free Cash Flow	$29.1M+755.4%	$3.4M+107.6%	-$44.9M-227.7%	$35.1M+1383.9%	$2.4M+107.5%	-$31.6M+56.7%	-$73.1M-280.6%	$40.5M
Investing Cash Flow	-$56.1M-12.6%	-$49.8M+17.7%	-$60.5M-4.6%	-$57.9M+0.9%	-$58.4M-41.4%	-$41.3M+94.8%	-$797.8M-1243.8%	-$59.4M
Financing Cash Flow	-$36.9M-692.3%	$6.2M-87.8%	$51.2M+354.9%	-$20.1M-13467.6%	-$148K-105.9%	$2.5M-99.7%	$864.5M+30898.2%	$2.8M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

ENOV Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	59.8%+3.8pp	56.0%-2.0pp	58.0%+2.4pp	55.6%+1.1pp	54.5%+0.7pp	53.9%
Operating Margin	-50.0%-13.2pp	-36.8%-33.0pp	-3.9%+0.7pp	-4.5%-0.2pp	-4.4%+1.5pp	-5.9%
Net Margin	-52.7%-13.5pp	-39.2%-37.2pp	-1.9%-1.1pp	-0.9%-5.9pp	5.0%+1.2pp	3.8%
Return on Equity	-79.5%-47.3pp	-32.2%-31.3pp	-1.0%-0.6pp	-0.4%-1.9pp	1.6%+0.3pp	1.2%
Return on Assets	-30.9%-13.4pp	-17.5%-16.8pp	-0.7%-0.4pp	-0.3%-1.1pp	0.8%+0.3pp	0.6%
Current Ratio	2.02-0.2	2.17-0.3	2.43+1.0	1.41-0.8	2.25+0.6	1.68
Debt-to-Equity	0.85+0.3	0.51+0.4	0.14+0.1	0.01-0.4	0.45-0.2	0.62
FCF Margin	0.9%+4.1pp	-3.2%-3.9pp	0.8%+11.1pp	-10.3%-28.0pp	17.7%+1.0pp	16.7%

Metric	Q4'25	Q3'25	Q2'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Gross Margin	59.9%+0.6pp	59.3%-0.2pp	59.5%+4.6pp	54.8%-1.9pp	56.7%+1.7pp	55.0%-2.7pp	57.7%-0.4pp	58.1%
Operating Margin	-101.7%-98.8pp	-3.0%+5.4pp	-8.4%+110.1pp	-118.5%-112.2pp	-6.3%+2.1pp	-8.4%-1.6pp	-6.8%-5.5pp	-1.3%
Net Margin	-104.0%-97.5pp	-6.5%+3.5pp	-10.0%+115.4pp	-125.4%-119.1pp	-6.2%-2.7pp	-3.5%+10.4pp	-14.0%-14.6pp	0.7%
Return on Equity	-28.3%-26.8pp	-1.4%+0.7pp	-2.1%+25.3pp	-27.5%-26.5pp	-0.9%-0.4pp	-0.6%+1.6pp	-2.2%-2.3pp	0.1%
Return on Assets	-12.9%-12.2pp	-0.7%+0.4pp	-1.1%+13.8pp	-14.9%-14.3pp	-0.6%-0.2pp	-0.3%+1.0pp	-1.3%-1.4pp	0.1%
Current Ratio	2.22-0.0	2.25-0.3	2.55+0.4	2.17-0.1	2.270.0	2.26+0.2	2.10-0.3	2.43
Debt-to-Equity	0.66+0.1	0.53+0.0	0.52+0.0	0.51+0.1	0.400.0	0.400.0	0.40+0.3	0.14
FCF Margin	5.3%+4.7pp	0.6%+8.6pp	-8.0%-14.3pp	6.3%+5.8pp	0.5%+6.5pp	-6.0%+8.1pp	-14.2%-23.1pp	8.9%

Similar Companies

Artivion, Inc. AORT

$1.7B

Conmed Corp CNMD

$1.1B

Ufp Technologies UFPT

$1.5B

Novocure NVCR

$1.2B

Integra Lifesciences Hldgs Cp IART

$749.8M

Frequently Asked Questions

What is Enovis Corp's annual revenue?

Enovis Corp (ENOV) reported $2.2B in total revenue for fiscal year 2025. This represents a 6.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Enovis Corp's revenue growing?

Enovis Corp (ENOV) revenue grew by 6.7% year-over-year, from $2.1B to $2.2B in fiscal year 2025.

Is Enovis Corp profitable?

No, Enovis Corp (ENOV) reported a net income of -$1.2B in fiscal year 2025, with a net profit margin of -52.7%.

What is Enovis Corp's EBITDA?

Enovis Corp (ENOV) had EBITDA of $219.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Enovis Corp have?

As of fiscal year 2025, Enovis Corp (ENOV) had $36.4M in cash and equivalents against $1.3B in long-term debt.

What is Enovis Corp's gross margin?

Enovis Corp (ENOV) had a gross margin of 59.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Enovis Corp's operating margin?

Enovis Corp (ENOV) had an operating margin of -50.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Enovis Corp's net profit margin?

Enovis Corp (ENOV) had a net profit margin of -52.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Enovis Corp's return on equity (ROE)?

Enovis Corp (ENOV) has a return on equity of -79.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Enovis Corp's free cash flow?

Enovis Corp (ENOV) generated $19.9M in free cash flow during fiscal year 2025. This represents a 129.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Enovis Corp's operating cash flow?

Enovis Corp (ENOV) generated $217.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Enovis Corp's total assets?

Enovis Corp (ENOV) had $3.8B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Enovis Corp's capital expenditures?

Enovis Corp (ENOV) invested $197.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Enovis Corp spend on research and development?

Enovis Corp (ENOV) invested $120.3M in research and development during fiscal year 2025.

Does Enovis Corp buy back shares?

Yes, Enovis Corp (ENOV) spent $3.5M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Enovis Corp have outstanding?

Enovis Corp (ENOV) had 57M shares outstanding as of fiscal year 2025.

What is Enovis Corp's current ratio?

Enovis Corp (ENOV) had a current ratio of 2.02 as of fiscal year 2025, which is generally considered healthy.

What is Enovis Corp's debt-to-equity ratio?

Enovis Corp (ENOV) had a debt-to-equity ratio of 0.85 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Enovis Corp's return on assets (ROA)?

Enovis Corp (ENOV) had a return on assets of -30.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Enovis Corp's Piotroski F-Score?

Enovis Corp (ENOV) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Enovis Corp's earnings high quality?

Enovis Corp (ENOV) has an earnings quality ratio of -0.18x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Enovis Corp cover its interest payments?

Enovis Corp (ENOV) has an interest coverage ratio of -32.3x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Enovis Corp?

Enovis Corp (ENOV) scores 32 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.